TMEM125
gene geneOn this page
Also known as MGC17299
Summary
TMEM125 (transmembrane protein 125, HGNC:28275) is a protein-coding gene on chromosome 1p34.2, encoding Transmembrane protein 125 (Q96AQ2).
Predicted to be located in membrane.
Source: NCBI Gene 128218 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 53 total
- MANE Select transcript:
NM_144626
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:28275 |
| Approved symbol | TMEM125 |
| Name | transmembrane protein 125 |
| Location | 1p34.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC17299 |
| Ensembl gene | ENSG00000179178 |
| Ensembl biotype | protein_coding |
| Entrez | 128218 |
Gene structure
Transcript identifiers
Ensembl transcripts: 35 — 34 protein_coding, 1 protein_coding_CDS_not_defined
ENST00000432792, ENST00000439858, ENST00000442284, ENST00000456751, ENST00000908432, ENST00000908433, ENST00000908434, ENST00000908435, ENST00000908436, ENST00000908437, ENST00000908438, ENST00000908439, ENST00000908440, ENST00000908441, ENST00000908442, ENST00000908443, ENST00000908444, ENST00000908445, ENST00000908446, ENST00000908447, ENST00000908448, ENST00000908449, ENST00000927383, ENST00000927384, ENST00000927385, ENST00000927386, ENST00000964004, ENST00000964005, ENST00000964006, ENST00000964007, ENST00000964008, ENST00000964009, ENST00000964010, ENST00000964011, ENST00000964012
RefSeq mRNA: 2 — MANE Select: NM_144626
NM_001320244, NM_144626
CCDS: CCDS480
Canonical transcript exons
ENST00000439858 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001254439 | 43272184 | 43272339 |
| ENSE00001593065 | 43272578 | 43274002 |
| ENSE00001649813 | 43270681 | 43270793 |
| ENSE00001672191 | 43269983 | 43270085 |
Expression profiles
Bgee: expression breadth ubiquitous, 209 present calls, max score 97.46.
FANTOM5 (CAGE): breadth broad, TPM avg 2.9285 / max 107.4333, expressed in 383 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 2502 | 2.7871 | 381 |
| 2499 | 0.1013 | 26 |
| 2500 | 0.0401 | 19 |
Top tissues by expression
252 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| ileal mucosa | UBERON:0000331 | 97.46 | gold quality |
| body of pancreas | UBERON:0001150 | 97.39 | gold quality |
| pancreatic ductal cell | CL:0002079 | 97.37 | gold quality |
| right lung | UBERON:0002167 | 96.92 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 96.78 | gold quality |
| upper lobe of lung | UBERON:0008948 | 96.58 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 95.74 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 95.68 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 94.49 | gold quality |
| thyroid gland | UBERON:0002046 | 94.42 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 93.62 | gold quality |
| lower lobe of lung | UBERON:0008949 | 93.58 | gold quality |
| lung | UBERON:0002048 | 93.49 | gold quality |
| spinal cord | UBERON:0002240 | 93.03 | gold quality |
| inferior vagus X ganglion | UBERON:0005363 | 92.94 | gold quality |
| right uterine tube | UBERON:0001302 | 92.93 | gold quality |
| pancreas | UBERON:0001264 | 92.83 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 92.30 | gold quality |
| duodenum | UBERON:0002114 | 91.43 | gold quality |
| pituitary gland | UBERON:0000007 | 91.28 | gold quality |
| bronchial epithelial cell | CL:0002328 | 91.17 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 91.02 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 90.81 | gold quality |
| bronchus | UBERON:0002185 | 90.77 | gold quality |
| adenohypophysis | UBERON:0002196 | 89.74 | gold quality |
| medial globus pallidus | UBERON:0002477 | 89.70 | gold quality |
| saliva-secreting gland | UBERON:0001044 | 89.09 | gold quality |
| metanephros cortex | UBERON:0010533 | 88.89 | gold quality |
| minor salivary gland | UBERON:0001830 | 88.84 | gold quality |
| globus pallidus | UBERON:0001875 | 88.48 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 3.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-HCAD-1 | yes | 87.25 |
| E-CURD-114 | yes | 43.46 |
| E-ANND-3 | yes | 23.67 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
16 targeting TMEM125, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4283 | 100.00 | 66.42 | 2097 |
| HSA-MIR-3134 | 100.00 | 66.43 | 777 |
| HSA-MIR-4279 | 99.19 | 66.70 | 2437 |
| HSA-MIR-6734-3P | 99.15 | 66.27 | 1627 |
| HSA-MIR-4764-5P | 98.88 | 65.53 | 894 |
| HSA-MIR-4700-5P | 98.63 | 67.43 | 1915 |
| HSA-MIR-3691-5P | 98.62 | 65.88 | 552 |
| HSA-MIR-8089 | 97.74 | 66.21 | 1698 |
| HSA-MIR-4667-5P | 97.61 | 66.67 | 1683 |
| HSA-MIR-4286 | 97.20 | 64.37 | 1587 |
| HSA-MIR-6729-3P | 96.91 | 66.79 | 703 |
| HSA-MIR-5194 | 96.77 | 63.91 | 1021 |
| HSA-MIR-6738-5P | 96.33 | 63.61 | 815 |
| HSA-MIR-362-5P | 95.87 | 66.02 | 554 |
| HSA-MIR-500B-5P | 95.87 | 66.04 | 557 |
| HSA-MIR-1914-3P | 95.07 | 63.37 | 762 |
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | tmem125b | ENSDARG00000075980 |
| mus_musculus | Tmem125 | ENSMUSG00000050854 |
| rattus_norvegicus | Tmem125 | ENSRNOG00000006924 |
Protein
Protein identifiers
Transmembrane protein 125 — Q96AQ2 (reviewed: Q96AQ2)
All UniProt accessions (2): E5RHB0, Q96AQ2
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Membrane.
RefSeq proteins (2): NP_001307173, NP_653227* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR028165 | TMEM125 | Family |
Pfam: PF15109
UniProt features (7 total): transmembrane region 4, sequence variant 2, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q96AQ2-F1 | 66.62 | 0.14 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 70 (showing top):
MYOGENIN_Q6, SP3_Q3, AREB6_01, SABATES_COLORECTAL_ADENOMA_SIZE_DN, AP4_Q6, CAGCTG_AP4_Q5, HEN1_01, chr1p34, TGIF_01, ARGGGTTAA_UNKNOWN, TGGAAA_NFAT_Q4_01, CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP, WGGAATGY_TEF1_Q6, LINDGREN_BLADDER_CANCER_CLUSTER_1_DN, XBP1_01
GO Biological Process (1): biological_process (GO:0008150)
GO Molecular Function (1): molecular_function (GO:0003674)
GO Cellular Component (2): membrane (GO:0016020), cellular_component (GO:0005575)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
476 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TMEM125 | FRAT2 | O75474 | 475 |
| TMEM125 | PLPPR2 | Q96GM1 | 469 |
| TMEM125 | CLDN19 | Q8N6F1 | 461 |
| TMEM125 | IER2 | Q9BTL4 | 442 |
| TMEM125 | KDF1 | Q8NAX2 | 431 |
| TMEM125 | SEL1L2 | Q5TEA6 | 408 |
| TMEM125 | ZNF442 | Q9H7R0 | 398 |
| TMEM125 | TAL1 | P17542 | 396 |
| TMEM125 | COL9A2 | Q14055 | 396 |
| TMEM125 | FZD10 | Q9ULW2 | 388 |
| TMEM125 | PHLDA1 | Q8WV24 | 388 |
| TMEM125 | TMEM42 | Q69YG0 | 373 |
| TMEM125 | SMIM8 | Q96KF7 | 370 |
| TMEM125 | ZSWIM1 | Q9BR11 | 365 |
| TMEM125 | ADNP | Q9H2P0 | 362 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A0A1B0GUA5, A0A1B0GVQ0, A0A286YF18, A0JNN8, A2VDX9, A5PK62, A6NGB7, A9CBA0, O09800, P04488, P06480, P06764, P07646, P0C171, P0DJK0, P0DJK1, P0DMQ5, P13291, P22389, P36342, P46695, P98162, Q08102, Q1RMT9, Q2HJ59, Q3TYP4, Q5BIR3, Q5EAA5, Q5JTB6, Q5NRQ0, Q6F5E0, Q6VUC0, Q6VUP9, Q703F0, Q765Z5, Q867A9, Q867D0, Q89448, Q8MJW9, Q8TEF2
Diamond homologs: Q2HJ59, Q8CHQ6, Q96AQ2
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
53 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 48 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
759 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:43272345:GGCC:G | donor_gain | 0.9900 |
| 1:43272952:T:A | acceptor_gain | 0.9900 |
| 1:43272182:A:AG | acceptor_gain | 0.9800 |
| 1:43272183:G:GG | acceptor_gain | 0.9800 |
| 1:43270794:G:GG | donor_gain | 0.9700 |
| 1:43272183:GCT:G | acceptor_gain | 0.9700 |
| 1:43272183:GCTC:G | acceptor_gain | 0.9700 |
| 1:43272335:GAGAG:G | donor_gain | 0.9700 |
| 1:43272338:AG:A | donor_loss | 0.9700 |
| 1:43272339:GGTCA:G | donor_loss | 0.9700 |
| 1:43272340:G:GA | donor_loss | 0.9700 |
| 1:43272961:T:A | acceptor_gain | 0.9700 |
| 1:43270079:G:T | donor_gain | 0.9600 |
| 1:43272337:GAG:G | donor_gain | 0.9600 |
| 1:43270083:G:GT | donor_gain | 0.9500 |
| 1:43272179:CACA:C | acceptor_loss | 0.9500 |
| 1:43272181:CA:C | acceptor_loss | 0.9500 |
| 1:43272182:AGCT:A | acceptor_loss | 0.9500 |
| 1:43272183:G:GT | acceptor_loss | 0.9500 |
| 1:43272256:T:A | acceptor_gain | 0.9500 |
| 1:43272332:G:GT | donor_gain | 0.9400 |
| 1:43272713:T:TA | acceptor_gain | 0.9400 |
| 1:43270033:G:GT | donor_gain | 0.9300 |
| 1:43270081:TGGAG:T | donor_loss | 0.9300 |
| 1:43270083:GAGGT:G | donor_loss | 0.9300 |
| 1:43270084:AGG:A | donor_loss | 0.9300 |
| 1:43270085:GG:G | donor_loss | 0.9300 |
| 1:43270086:G:GA | donor_loss | 0.9300 |
| 1:43270087:T:A | donor_loss | 0.9300 |
| 1:43271082:G:GT | donor_gain | 0.9300 |
AlphaMissense
1360 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:43272918:T:A | W66R | 0.994 |
| 1:43272918:T:C | W66R | 0.994 |
| 1:43272920:G:C | W66C | 0.994 |
| 1:43272920:G:T | W66C | 0.994 |
| 1:43273080:A:C | S120R | 0.994 |
| 1:43273082:T:A | S120R | 0.994 |
| 1:43273082:T:G | S120R | 0.994 |
| 1:43272945:T:C | C75R | 0.991 |
| 1:43272974:A:C | K84N | 0.989 |
| 1:43272974:A:T | K84N | 0.989 |
| 1:43273004:G:A | M94I | 0.989 |
| 1:43273004:G:C | M94I | 0.989 |
| 1:43273004:G:T | M94I | 0.989 |
| 1:43272803:G:C | W27C | 0.987 |
| 1:43272803:G:T | W27C | 0.987 |
| 1:43272933:G:C | G71R | 0.987 |
| 1:43272984:A:C | S88R | 0.987 |
| 1:43272986:C:A | S88R | 0.987 |
| 1:43272986:C:G | S88R | 0.987 |
| 1:43272973:A:T | K84I | 0.986 |
| 1:43273104:G:C | G128R | 0.986 |
| 1:43272934:G:A | G71D | 0.985 |
| 1:43273000:A:C | D93A | 0.985 |
| 1:43273083:G:C | G121R | 0.985 |
| 1:43272979:T:C | L86P | 0.984 |
| 1:43273000:A:T | D93V | 0.984 |
| 1:43272868:G:A | G49D | 0.983 |
| 1:43273194:G:C | G158R | 0.983 |
| 1:43272864:T:C | C48R | 0.982 |
| 1:43272877:G:A | G52D | 0.982 |
dbSNP variants (sampled 300 via entrez): RS1000558724 (1:43271112 A>T), RS1000611000 (1:43270741 C>A,T), RS1002115261 (1:43271585 G>A,T), RS1002189948 (1:43269683 C>T), RS1002243760 (1:43270103 G>A), RS1002255048 (1:43271794 A>G), RS1003928583 (1:43268284 A>G), RS1004453393 (1:43270631 G>A,C), RS1005506144 (1:43271804 C>T), RS1005647027 (1:43270154 G>A,T), RS1006401952 (1:43271879 G>GA), RS1006782859 (1:43270711 G>A,C), RS1006961352 (1:43272198 C>G), RS1007920131 (1:43273354 C>T), RS1008450620 (1:43272223 G>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
33 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | increases expression, affects cotreatment | 4 |
| sodium arsenite | decreases expression | 2 |
| entinostat | increases expression, affects cotreatment | 2 |
| Panobinostat | affects cotreatment, increases expression | 2 |
| Air Pollutants | decreases expression, increases abundance, increases expression | 2 |
| Estradiol | affects cotreatment, decreases expression | 2 |
| Smoke | decreases expression, increases abundance, increases expression | 2 |
| Cadmium Chloride | decreases expression, increases expression | 2 |
| trichostatin A | increases expression | 1 |
| tobacco tar | decreases expression | 1 |
| hydroquinone | increases expression | 1 |
| tebuconazole | decreases expression | 1 |
| CGP 52608 | increases reaction, affects binding | 1 |
| 2-palmitoylglycerol | increases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, increases expression | 1 |
| ICG 001 | increases expression | 1 |
| dorsomorphin | affects cotreatment, increases expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Zoledronic Acid | decreases expression | 1 |
| Acetaminophen | decreases expression | 1 |
| Benzo(a)pyrene | affects methylation, decreases methylation | 1 |
| Dichlorodiphenyl Dichloroethylene | decreases expression | 1 |
| Folic Acid | decreases expression | 1 |
| Hydrogen Peroxide | affects expression | 1 |
| Mustard Gas | increases expression | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Silicon Dioxide | decreases expression | 1 |
| Sodium Dodecyl Sulfate | increases expression | 1 |
| Tretinoin | increases expression | 1 |
| Antirheumatic Agents | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.